Leptin Analog [EPC]

1263 reported adverse events

Drugs of this class: METRELEPTIN

These side effects are most commonly reported by patients taking drugs of the Leptin Analog [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 102
1 WEIGHT DECREASED 93
2 THERAPY CESSATION 92
3 BLOOD GLUCOSE INCREASED 84
4 DRUG INEFFECTIVE 77
5 OFF LABEL USE 68
6 THERAPY INTERRUPTED 66
7 NAUSEA 61
8 BLOOD TRIGLYCERIDES INCREASED 54
9 TREATMENT NONCOMPLIANCE 53
See all common reactions for Leptin Analog [EPC]

Drugs of the Leptin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LEPTIN LEVEL DECREASED 3 0.7500
1 LEPTIN LEVEL INCREASED 3 0.2727
2 DIET NONCOMPLIANCE 17 0.0462
3 NEUTRALISING ANTIBODIES POSITIVE 19 0.0456
4 ALPHA TUMOUR NECROSIS FACTOR INCREASED 3 0.0323
5 NEUTRALISING ANTIBODIES 3 0.0238
6 INSULIN RESISTANCE 33 0.0158
7 FAT TISSUE DECREASED 6 0.0154
8 XANTHOMA 3 0.0149
9 BLOOD TRIGLYCERIDES DECREASED 4 0.0119
See all enriched reactions for Leptin Analog [EPC]